OCEA logo

Ocean Biomedical (OCEA) Financials

Balance sheets

31 Dec 202330 Sept 202330 June 202331 Mar 202331 Dec 202230 Sept 202230 June 2022

Total Assets

$5.5 M(+433.6%)$1.0 M(-95.1%)$20.9 M(-16.2%)$25.0 M(-77.5%)$110.9 M-$395.0 K

Current Assets

$2.1 M(+104.6%)$1.0 M(-52.3%)$2.2 M(+606.2%)$306.0 K(-34.6%)$468.0 K-$395.0 K

Non Current Assets

$3.4 M(+100.0%)$0.0(-100.0%)$18.8 M(-24.0%)$24.7 M(-77.7%)$110.4 M-$0.0

Total Liabilities

$96.3 M(+26.2%)$76.3 M(+160.1%)$29.3 M(+25.1%)$23.4 M(+254.3%)$6.6 M-$9.9 M

Current Liabilities

$30.0 M(-2.7%)$30.9 M(+15.6%)$26.7 M(+13.8%)$23.4 M(+576.5%)$3.5 M-$9.9 M

Long Term Liabilities

$66.3 M(+45.9%)$45.4 M(+1617.9%)$2.6 M(+100.0%)$0.0(-100.0%)$3.1 M-$0.0

Shareholders Equity

-$90.8 M(-20.7%)-$75.2 M(-795.4%)-$8.4 M(-644.1%)$1.5 M(-98.5%)$104.3 M--$9.5 M

Book Value

-$90.8 M(-20.7%)-$75.2 M(-795.4%)-$8.4 M(-644.1%)$1.5 M(-98.5%)$104.3 M--$9.5 M

Working Capital

-$27.9 M(+6.4%)-$29.8 M(-21.6%)-$24.5 M(-6.0%)-$23.1 M(-672.0%)-$3.0 M--$9.5 M

Cash And Cash Equivalents

$4000.0(-87.1%)$31.0 K(-97.3%)$1.2 M(+279.4%)$306.0 K(-6.8%)$328.3 K-$395.0 K

Accounts Payable

$933.0 K(+718.4%)$114.0 K(-91.7%)$1.4 M(-18.1%)$1.7 M(+419.0%)$324.8 K-$528.0 K

Accounts Receivable

-------

Short Term Debt

$12.1 M(+0.6%)$12.1 M(+1.5%)$11.9 M(+67.9%)$7.1 M(+228.8%)$2.1 M-$764.0 K

Long Term Debt

-------

Total Debt

$12.1 M(+0.6%)$12.1 M(+1.5%)$11.9 M(+67.9%)$7.1 M(+228.8%)$2.1 M-$764.0 K

Debt To Equity

-0.1(+18.8%)-0.2(+88.7%)-1.4(-130.8%)4.6(+22800.0%)0.0--0.1

Current Ratio

0.1(+133.3%)0.0(-62.5%)0.1(+700.0%)0.0(-92.9%)0.1-0.0

Quick Ratio

-------

Inventory

-------

Retained Earnings

-$196.1 M(-9.4%)-$179.2 M(-10.6%)-$162.0 M(-8.7%)-$149.0 M(-5286.7%)-$2.8 M--$76.9 M

PB Ratio

-------

Income statements

31 Dec 202330 Sept 202330 June 202331 Mar 202331 Dec 202230 Sept 202230 June 2022

EPS

--$0.5(-23.3%)-$0.4(+85.2%)-$2.9--$0.2(+50.0%)-$0.4

TTM EPS

--$3.9(-9.9%)-$3.5(-1.9%)-$3.4--$0.5(-50.0%)-$0.4

Revenue

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

TTM Revenue

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

Total Expenses

-$660.0 K(-124.9%)$2.7 M(-6.3%)$2.8 M(-47.4%)$5.4 M(+142.4%)-$12.7 M(-500.3%)$3.2 M(-54.0%)$6.9 M

Operating Expenses

-$660.0 K(-124.9%)$2.7 M(-6.3%)$2.8 M(-47.4%)$5.4 M(+142.4%)-$12.7 M(-500.3%)$3.2 M(-54.0%)$6.9 M

Cost Of Goods Sold

-------

TTM Cost Of Goods Sold

-------

Gross Profit

-------

TTM Gross Profit

-------

Gross Margin

-------

Operating Profit

$660.0 K(+124.9%)-$2.7 M(+6.3%)-$2.8 M(+47.4%)-$5.4 M(-142.4%)$12.7 M(+500.3%)-$3.2 M(+54.0%)-$6.9 M

TTM Operating Profit

-$10.2 M(-659.0%)$1.8 M(+39.6%)$1.3 M(+147.5%)-$2.8 M(-205.0%)$2.6 M(+126.1%)-$10.1 M(-46.0%)-$6.9 M

Operating Margin

-------

Net Income

-$16.9 M(-19.7%)-$14.1 M(-23.2%)-$11.4 M(+84.1%)-$72.1 M(-567.6%)$15.4 M(+520.3%)-$3.7 M(+50.0%)-$7.3 M

TTM Net Income

-$114.5 M(-39.3%)-$82.2 M(-14.5%)-$71.8 M(-6.1%)-$67.7 M(-1632.3%)$4.4 M(+140.2%)-$11.0 M(-50.0%)-$7.3 M

Net Margin

-------

EBIT

-$16.4 M(-18.6%)-$13.8 M(-28.2%)-$10.8 M(+85.0%)-$71.8 M(-569.5%)$15.3 M(+524.0%)-$3.6 M(+47.7%)-$6.9 M

TTM EBIT

-$112.7 M(-39.0%)-$81.1 M(-14.4%)-$70.9 M(-5.8%)-$67.0 M(-1500.6%)$4.8 M(+145.5%)-$10.5 M(-52.3%)-$6.9 M

EBITDA

-$874.0 K(+68.4%)-$2.8 M(+18.9%)-$3.4 M(+36.7%)-$5.4 M(-135.2%)$15.3 M(+582.1%)-$3.2 M(+54.0%)-$6.9 M

TTM EBITDA

-$12.4 M(-433.9%)$3.7 M(+12.2%)$3.3 M(+2068.3%)-$168.7 K(-103.2%)$5.2 M(+151.8%)-$10.1 M(-46.0%)-$6.9 M

Selling, General & Administrative Expenses

-$643.0 K(-127.4%)$2.4 M(-16.2%)$2.8 M(-43.9%)$5.0 M-$1.3 M(-64.5%)$3.7 M

TTM SG&A

$9.5 M(-6.3%)$10.1 M(+11.4%)$9.1 M(-9.0%)$10.0 M-$5.0 M(+35.5%)$3.7 M

Depreciation And Amortization

-------

TTM D&A

-------

Interest Expense

$500.0 K(+70.7%)$293.0 K(-56.1%)$668.0 K(+121.9%)$301.0 K(+340.2%)-$125.3 K(-305.4%)$61.0 K(+24.5%)$49.0 K

TTM Interest Expense

$1.8 M(+55.0%)$1.1 M(+25.6%)$904.7 K(+216.7%)$285.7 K(+1966.2%)-$15.3 K(-113.9%)$110.0 K(+124.5%)$49.0 K

Income Tax

-------

TTM Income Tax

-------

PE Ratio

-------

PS Ratio

-------

Cashflow statements

31 Dec 202330 Sept 202330 June 202331 Mar 202331 Dec 202230 Sept 202230 June 2022

Cash From Operations

-$866.0 K(+23.4%)-$1.1 M(+78.0%)-$5.1 M(-124.2%)-$2.3 M(-1178.0%)$212.7 K(+148.2%)-$441.0 K(-190.1%)-$152.0 K

TTM CFO

-$9.4 M(-12.9%)-$8.4 M(-9.0%)-$7.7 M(-186.6%)-$2.7 M(-603.0%)-$380.3 K(+35.9%)-$593.0 K(-290.1%)-$152.0 K

Cash From Investing

-------

TTM CFI

-------

Cash From Financing

$839.0 K(+100.0%)$0.0(-100.0%)$6.6 M(+127.1%)$2.9 M(+169.7%)$1.1 M(+569.1%)$162.0 K(-36.5%)$255.0 K

TTM CFF

$10.4 M(-2.3%)$10.6 M(-1.5%)$10.8 M(+144.3%)$4.4 M(+194.7%)$1.5 M(+259.9%)$417.0 K(+63.5%)$255.0 K

Free Cash Flow

-$866.0 K(+23.4%)-$1.1 M(+76.4%)-$4.8 M(-80.4%)-$2.7 M(-1346.3%)$212.7 K(+148.1%)-$442.0 K(-190.8%)-$152.0 K

TTM FCF

-$9.4 M(-12.9%)-$8.4 M(-9.0%)-$7.7 M(-152.7%)-$3.0 M(-695.3%)-$381.3 K(+35.8%)-$594.0 K(-290.8%)-$152.0 K

CAPEX

-------

TTM CAPEX

-------

Dividends Paid

-------

TTM Dividends Paid

-------

TTM Dividend Per Share

-------

TTM Dividend Yield

-------

Payout Ratio

-------